 MENAFN.COM |
Invion starts second phase trial for asthma treatment
MENAFN.COM (MENAFN – ProactiveInvestors – Australia) Invion (ASX: IVX) has initiated the phase II "NIMA" clinical trial to investigate the use of INV102 in patients with mild asthma. The trail, which is funded by the U.S. National Institute of Allergy and … |
View full post on asthma – Google News